Source: Annual Congress 2004 - Heart and lung
Disease area: Respiratory critical care, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
G. Chua, A. P. Chua, S. Sethi, T. K. Lim (Nuh, Singapore). The incidence and significance of elevated B-type natriuretic peptide levels in patients hospitalized with apparent respiratory diseases. Eur Respir J 2004; 24: Suppl. 48, 1814

Member's Comments

No comment yet.

Related content which might interest you: Diagnostic value of N-terminal pro-brain natriuretic peptide in patients with COPD with chronic hypoxemic respiratory failure. Source: Virtual Congress 2020 – COPD and the impact of comorbidities Year: 2020 Serum levels of high sensitivity cardiac troponin and B-type natriuretic peptide in patients with COPD-OSA overlap syndrome Source: Sleep and Breathing Conference 2021 Year: 2021 B-type natriuretic peptide (BNP) in COPD patients with acute respiratory failure (ARF) Source: Annual Congress 2010 - COPD: cardiovascular comorbidities Year: 2010 The use of plasma n-terminal pro B-type natriuretic peptide (proBNP) concentrations in differential diagnosis of comorbidity pulmonary patients Source: Annual Congress 2011 - Acute respiratory failure Year: 2011 Brain natriuretic peptide (BNP) determination in patients hospitalized for COPD exacerbation Source: Annual Congress 2008 - Biomarkers and disease assessment in COPD Year: 2008 The utility of brain natriuretic peptide in patients with stable chronic lung diseases Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH and associated PH Year: 2012 Brain natriuretic peptide (BNP) levels during acute exacerbations of COPD – a novel biomarker Source: Annual Congress 2008 - Mechanisms of respiratory infections: interaction between the pathogen and the host Year: 2008 Pro-adrenomedullin, pro-atrial natriuretic peptide and procalcitonin levels at admission in patients with community-acquired pneumonia and its correlation with risk scores Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia Year: 2011 Pro-atrial natriuretic peptide and pro-vasopressin to predict severity and prognosis in community-acquired pneumonia Source: Eur Respir J 2007; 30: Suppl. 51, 481s Year: 2007 The role of N-terminal pro B-type natriuretic peptide in predicting mortality of community acquired pneumonia Source: International Congress 2019 – Pneumonia in 2019: antimicrobial resistance, cardiovascular complications and diagnosis Year: 2019 Levels of procalcitonin, neopterin, C-reactive protein and pro-atrial natriuretic peptide in patients with community-acquired pneumonia and its kinetic according to the severity and the development of complications Source: Annual Congress 2010 - Treatment and risk factors in lower respiratory tract infections Year: 2010 The effect of diuretics on plasma brain natriuretic peptide level in patients with acute exacerbations of chronic obstructive pulmonary disease Source: Annual Congress 2007 - Treatment of COPD Year: 2007 N-terminal-pro-B-type natriuretic peptide (NT-proBNP) in patient with acute exacerbations (AE) of COPD Source: Annual Congress 2008 - Biomarkers and disease assessment in COPD Year: 2008 Association between obstructive sleep apnea and elevated levels of B-type natriuretic peptide in a community based sample of women Source: Annual Congress 2012 - Physiology, obesity and the downstream effects of OSA Year: 2012 Determination of B-type natriuretic peptide in patients with chronic heart failure and Cheyne-Stokes respiration Source: Eur Respir J 2004; 24: Suppl. 48, 563s Year: 2004 Prognostic value of serum N-terminal brain natriuretic peptide type B for pulmonary hypertension among patients with usual interstitial pneumonia and sarcoidosis Source: Annual Congress 2007 - Pulmonary vascular involvement in smoking and respiratory diseases Year: 2007 Role of B-type brain natriuretic peptide in the development of fluid retention and detection of right ventricular failure in COPD patients Source: Eur Respir J 2004; 24: Suppl. 48, 305s Year: 2004 The prognostic value of repeated measurements of N-terminal pro-B-type natriuretic peptide in patients with pulmonary hypertension Source: Annual Congress 2010 - Pulmonary circulation: clinical aspects Year: 2010 Presence of inspiratory crackles (IC) in stable chronic obstructive pulmonary disease (COPD) patients; correlation with plasma N-terminal pro-brain natriuretic peptide (NT-BNP) levels Source: Annual Congress 2008 - Assessment of the respiratory system Year: 2008 Elevated brain natriuretic peptide predicts mortality in interstitial lung disease Source: Eur Respir J 2010; 36: 819-825 Year: 2010